CON on NYSE

Concentra Group Holdings Parent, Inc.

Concentra Group Holdings Parent, Inc. is an American specialty outpatient facilities services company, listed on NYSE (CON).1 It is headquartered in Addison, Texas.1

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with Acadia Healthcare, Elite Health Systems Inc. or BioCorRx Inc., or pick any stock.

  • TickerCON on NYSE1
  • IndustryServices-Specialty Outpatient Facilities, NEC1
  • HeadquartersAddison, Texas1
  • Incorporated inDE2
  • Business address5080 Spectrum Drive, Suite 1200W, Addison, Tx 750012
  • Filer categoryLarge accelerated filer2

We were founded in 1979 and have grown to be the largest provider of occupational health services in the United States by number of locations. Our national presence enables us to provide access to high-quality care that supports our mission to improve the health of America’s workforce. As of December 31, 2025, we operated 628 stand-alone occupational health centers in 41 states and 411 onsite health clinics at employer worksites in 44 states. We also have expanded our reach via our telemedicine program serving 43 states and the District of Columbia. In total, we deliver services across 47 states and the District of Columbia. We had approximately 13,000 colleagues and affiliated physicians and clinicians as of December 31, 2025 who supported the delivery of an extensive suite of services, including occupational and consumer health services and other direct-to-employer care to approximatel…4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

15.4%Operating margin5
7.7%Net margin5
13.9%Revenue growth, 20255
42.3%Return on equity5
$197.1MFree cash flow5

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Other costs90¢$1.9B
  • Income tax2¢$51.0M
  • Profit8¢$166.4M

Out of $2.2B in revenue.5

Where each dollar of operating cash went, fiscal 2025

  • Capital spending29¢$82.3M
  • Dividends paid11¢$32.1M
  • Share buybacks8¢$22.4M
  • Kept or used elsewhere51¢$142.6M

Out of $279.4M of cash from operations.5

Financial statements

Revenue65$2.2B in 2025+25% since 2022
0$1.0B$2.0B$3.0B2022: $1.7B$1.7B20222023: $1.8B$1.8B2023+7%2024: $1.9B$1.9B2024+3%2025: $2.2B$2.2B2025+14%
Operating income65$334.0M in 2025+29% since 2022
0$100.0M$200.0M$300.0M$400.0M2022: $258.5M$258.5M20222023: $287.6M$287.6M2023+11%2024: $304.8M$304.8M2024+6%2025: $334.0M$334.0M2025+10%
Net income65$166.4M in 2025−0% since 2022
0$50.0M$100.0M$150.0M$200.0M2022: $166.7M$166.7M20222023: $179.9M$179.9M2023+8%2024: $166.5M$166.5M2024−7%2025: $166.4M$166.4M2025−0%
Fiscal year20212022202320242025
Revenue$1.7B6$1.8B5$1.9B5$2.2B5
Operating expenses$1.5B6$1.6B5$1.6B5$1.8B5
Operating income$258.5M6$287.6M5$304.8M5$334.0M5
Income before tax$224.9M6$242.6M5$231.4M5$223.8M5
Income tax$52.7M6$57.9M5$59.5M5$51.0M5
Net income$166.7M6$179.9M5$166.5M5$166.4M5
Earnings per share$1.606$1.735$1.465$1.305
Earnings per share (diluted)$1.606$1.735$1.465$1.305
Shares (weighted, basic)103.8M shares6104.0M shares5114.1M shares5126.6M shares5
Shares (weighted, diluted)103.8M shares6104.2M shares5114.2M shares5128.3M shares5

Compare Concentra Group Holdings Parent, Inc. with another company

Corporate structure

Concentra Group Holdings Parent, Inc. sits at the top of its group. 24 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Concentra Group Holdings Parent, Inc.

  • ORTENZIO ROBERT A Filed SCHEDULE 13D/A on Concentra Group Holdings Parent, Inc., latest Sep 1, 2026 (5 filings since Dec 3, 2024)
  • BlackRock Filed SCHEDULE 13G/A on Concentra Group Holdings Parent, Inc., latest Jul 27, 2026 (3 filings since Dec 6, 2024)
  • VANGUARD PORTFOLIO MANAGEMENT LLC Filed SCHEDULE 13G on Concentra Group Holdings Parent, Inc., latest Apr 29, 2026
  • VANGUARD GROUP INC Filed SCHEDULE 13G/A on Concentra Group Holdings Parent, Inc., latest Mar 26, 2026 (3 filings since Jan 30, 2025)
  • PRICE T ROWE ASSOCIATES INC /MD/ Filed SCHEDULE 13G/A on Concentra Group Holdings Parent, Inc., latest Feb 17, 2026 (4 filings since Dec 9, 2024)
  • T. Rowe Price Investment Management, Inc. Filed SCHEDULE 13G/A on Concentra Group Holdings Parent, Inc., latest Nov 14, 2025 (2 filings since Feb 14, 2025)
  • Rocco A. Ortenzio Filed SCHEDULE 13D/A on Concentra Group Holdings Parent, Inc., latest Mar 4, 2025 (2 filings since Dec 3, 2024)
  • Select Medical Filed SC 13G/A on Concentra Group Holdings Parent, Inc., latest Nov 27, 2024 (2 filings since Sep 5, 2024)
  • Concentra Group Holdings Parent, Inc. Addison, Texas
    • Concentra Akron, L.L.C. Subsidiary · Delaware, United States
    • Concentra Arkansas, L.L.C. Subsidiary · Delaware, United States
    • Concentra Green Bay, L.L.C. Subsidiary · Delaware, United States
    • Concentra Group Holdings, LLC Subsidiary · Delaware, United States
    • Concentra Health Services, Inc. Subsidiary · Nevada, United States
    • Concentra Holdings, Inc. Subsidiary · Delaware, United States
    • Concentra Integrated Services, Inc. Subsidiary · Massachusetts, United States
    • Concentra Occupational Healthcare Harrisburg, L.P. Subsidiary · Pennsylvania, United States
    • Concentra St. Louis, L.L.C. Subsidiary · Delaware, United States
    • Concentra Ventures, Inc. Subsidiary · Delaware, United States
    • Concentra – UPMC, L.L.C. Subsidiary · Delaware, United States
    • ConcentraMark, Inc. Subsidiary · Delaware, United States
    • ContinuityRx, Inc. Subsidiary · Arizona, United States
    • Occuflex Software Solutions, LLC Subsidiary · Texas, United States
    • Occupational Health + Rehabilitation, LLC Subsidiary · Delaware, United States
    • OHR/Baystate, LLC Subsidiary · Massachusetts, United States
    • OHR/MMC, Limited Liability Company Subsidiary · Maine, United States
    • Onsite Innovations, LLC Subsidiary · Delaware, United States
    • Patient Transport Services, LLC Subsidiary · Texas, United States
    • St. Mary’s Medical Park Pharmacy, Inc. Subsidiary · Arizona, United States
    • U.S. HealthWorks Medical Group of Alaska, LLC Subsidiary · Alabama, United States
    • U.S. Healthworks, Inc. Subsidiary · Delaware, United States
    • U.S. Occmed Holdings, LLC Subsidiary · Texas, United States

Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Concentra Group Holdings Parent, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Finance-lease assets$1.2M5 Dec 31, 2025$1.7M5 Dec 31, 2024−30.6%
Operating-lease assets (leased space)$483.7M5 Dec 31, 2025$435.6M5 Dec 31, 2024+11.0%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$79.9M5 Dec 31, 2025$183.3M5 Dec 31, 2024−56.4%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$1.5B5 Dec 31, 2025$1.2B5 Dec 31, 2024+19.8%
Intangible assets, net (excluding goodwill)$242.6M5 Dec 31, 2025$204.7M5 Dec 31, 2024+18.5%
Accumulated amortization$260.4M5 Dec 31, 2025$233.1M5 Dec 31, 2024+11.7%

Properties, in its own words

We currently lease most of our consolidated facilities, including our occupational health centers, and our corporate headquarters. We own nine of our occupational health centers throughout the United States. Our facilities cover approximately 5 million square feet as of December 31, 2025, consisting of approximately 100,000 square feet in facilities that we own, and the remainder in facilities that we lease or otherwise have rights to use. These facilities are located throughout the United States. The following is a list by state of the number of facilities we operated as of December 31, 2025.

Alaska · 1

The rest of Item 2

Arizona · 16

Arkansas · 2

California · 101

Colorado · 26

Connecticut · 10

Delaware · 3

Florida · 39

Georgia · 23

Hawaii · 1

Illinois · 19

Indiana · 18

Iowa · 3

Kansas · 4

Kentucky · 8

Louisiana · 3

Maine · 7

Maryland · 13

Massachusetts · 2

Michigan · 19

Minnesota · 6

Missouri · 15

Nebraska · 3

Nevada · 7

New Hampshire · 3

New Jersey · 24

New Mexico · 4

North Carolina · 8

Ohio · 18

Oklahoma · 8

Oregon · 4

Pennsylvania · 32

Rhode Island · 2

South Carolina · 5

Tennessee · 16

Texas · 100

Utah · 6

Vermont · 2

Virginia · 11

Washington · 16

Wisconsin · 20

Total Company · 628

Item 2 of the 10-K filed Feb 26, 2026.4

Leadership

Who has led Concentra Group Holdings Parent, Inc., and when. Pick a name to see everywhere that person has worked.

Board members and other officers (17)

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

  • Concentra Akron, L.L.C. Delaware3
  • Concentra Arkansas, L.L.C. Delaware3
  • Concentra Green Bay, L.L.C. Delaware3
  • Concentra Group Holdings, LLC Delaware3
  • Concentra Health Services, Inc. Nevada3
  • Concentra Holdings, Inc. Delaware3
  • Concentra Integrated Services, Inc. Massachusetts3
  • Concentra Occupational Healthcare Harrisburg, L.P. Pennsylvania3
  • Concentra St. Louis, L.L.C. Delaware3
  • Concentra Ventures, Inc. Delaware3
  • Concentra – UPMC, L.L.C. Delaware3
  • ConcentraMark, Inc. Delaware3
  • ContinuityRx, Inc. Arizona3
  • OHR/Baystate, LLC Massachusetts3
  • OHR/MMC, Limited Liability Company Maine3
  • Occuflex Software Solutions, LLC Texas3
  • Occupational Health + Rehabilitation, LLC Delaware3
  • Onsite Innovations, LLC Delaware3
  • Patient Transport Services, LLC Texas3
  • St. Mary’s Medical Park Pharmacy, Inc. Arizona3
  • U.S. HealthWorks Medical Group of Alaska, LLC Alabama3
  • U.S. Healthworks, Inc. Delaware3
  • U.S. Occmed Holdings, LLC Texas3

The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Timeline

  1. Sep 8, 20268-K Executive or director change; Regulation FD disclosure26
  2. Aug 27, 20268-K Entered a material agreement27
  3. Aug 6, 20268-K Results of operations; Executive or director change; Regulation FD disclosure28
  4. Jul 10, 20268-K Executive or director change29
  5. May 7, 20268-K Results of operations; Regulation FD disclosure; Other events30
  6. Apr 30, 20268-K Shareholder vote31
  7. Apr 14, 20268-K Executive or director change; Regulation FD disclosure32
  8. Feb 26, 20268-K Results of operations; Regulation FD disclosure; Other events33
  9. Jan 28, 20268-K Results of operations; Regulation FD disclosure34
  10. Jan 12, 20268-K Results of operations; Regulation FD disclosure35
  11. Nov 10, 20258-K Executive or director change36
  12. Nov 6, 20258-K Results of operations; Regulation FD disclosure; Other events37
  13. Jul 24, 2024New chief executive William Keith Newton becomes CEO9

Calendar

Coming up

  1. Nov 5, 2026 · After the closeReports results for the quarter ending Sep/2026 A year earlier it reported $0.39 a share, on Nov 6, 2025.38

When it reported results

  1. Aug 6, 2026Reported quarterly or annual results28
  2. May 7, 2026Reported quarterly or annual results30
  3. Feb 26, 2026Reported quarterly or annual results33
  4. Jan 28, 2026Reported quarterly or annual results34
  5. Jan 12, 2026Reported quarterly or annual results35
  6. Nov 6, 2025Reported quarterly or annual results37
  7. Aug 7, 2025Reported quarterly or annual results39
  8. May 7, 2025Reported quarterly or annual results40

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

179 filings to the SEC since October 2021: 2 annual reports, 7 quarterly reports, 28 major events, 86 insider forms, 22 large holders, 34 other. The latest 20:

  1. Sep 8, 20268-K EDGAR
  2. Sep 1, 2026SCHEDULE 13D/A EDGAR
  3. Sep 1, 20264/A EDGAR
  4. Aug 27, 20268-K EDGAR
  5. Aug 25, 20264 EDGAR
  6. Aug 24, 2026SCHEDULE 13D/A EDGAR
  7. Aug 6, 202610-Q EDGAR
  8. Aug 6, 20268-K EDGAR
  9. Aug 5, 20264 EDGAR
  10. Aug 3, 2026144 EDGAR
  11. Jul 27, 2026SCHEDULE 13G/A EDGAR
  12. Jul 10, 20268-K EDGAR
  13. Jul 6, 20264 EDGAR
  14. Jul 1, 2026144 EDGAR
  15. Jun 30, 2026144 EDGAR
  16. Jun 29, 2026144 EDGAR
  17. Jun 26, 2026144/A EDGAR
  18. Jun 26, 2026144 EDGAR
  19. Jun 2, 20264 EDGAR
  20. Jun 1, 2026144 EDGAR

The 179 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

4 open-market trades by officers, directors and large owners since October 2021: 0 buys and 4 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Aug 3, 2026ORTENZIO ROBERT ADirectorSale130,000$31.84$4.1MForm 4
Jul 1, 2026ORTENZIO ROBERT ADirectorSale130,000$30.50$4.0MForm 4
Jun 1, 2026ORTENZIO ROBERT ADirectorSale130,000$25.00$3.2MForm 4
May 8, 2026ORTENZIO ROBERT ADirectorSale130,000$25.00$3.2MForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

YearExecutiveAgeSalaryTotal pay
2025William K. NewtonChief Executive Officer (Principal Executive Officer)62$843.1K$7.4M49
2025Matthew T. DiCanioPresident and Chief Financial Officer (Principal Financial Officer)$573.8K$5.3M49
2025John A. deLorimierExecutive Vice President, Chief Information and Technology Officer$450.0K$2.3M49
2025Timothy RyanExecutive Vice President and Chief Legal Counsel$450.0K$2.3M49
2025John AndersonExecutive Vice President, Chief Medical Officer$450.0K$2.3M49
2024William K. NewtonChief Executive Officer (Principal Executive Officer)62$700.0K$7.1M49
2024Matthew T. DiCanioPresident and Chief Financial Officer (Principal Financial Officer)$550.0K$6.6M49
2024John A. deLorimierExecutive Vice President, Chief Information and Technology Officer$450.0K$2.8M49
2024John AndersonExecutive Vice President, Chief Medical Officer$450.0K$2.8M49
2023William K. NewtonChief Executive Officer (Principal Executive Officer)62$700.0K$7.0M49
2023Matthew T. DiCanioPresident and Chief Financial Officer (Principal Financial Officer)$495.2K$1.6M49
2023John A. deLorimierExecutive Vice President, Chief Information and Technology Officer$450.0K$1.4M49

SEC filer profile

How Concentra Group Holdings Parent, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARConcentra Group Holdings Parent, Inc.1
  • CIK0002014596
  • Employer ID (EIN)30-10066134
  • Filer statusLarge accelerated filer not an emerging growth company; not a smaller reporting company; not a shell company4
  • Incorporated inDelaware4
  • Fiscal year endsDecember 311
  • Industry code (SIC)8093 Services-Specialty Outpatient Facilities, NEC1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address5080 Spectrum Drive, Suite 1200W, Addison, TX 750011
  • Phone(972) 364-80001
  • Shares outstanding127,517,736 as of Jul 31, 20268
  • Public float$2.4B as of Jun 30, 20254
  • AuditorPricewaterhouseCoopers LLP, Dallas, Texas PCAOB ID 238; it also attests to the company’s internal control over financial reporting4
  • On EDGAR sinceMar 11, 20241
  • Filings179 in all: 4 (64), 8-K (28), 3 (21), SCHEDULE 13G/A (8), 10-Q (7), 144 (7), SCHEDULE 13D/A (5), DRS/A (3)1
    All 29 form types

    DRSLTR (3), SC 13G (3), SCHEDULE 13G (3), UPLOAD (3), 10-K (2), ARS (2), CORRESP (2), DEF 14A (2), DEFA14A (2), S-1/A (2), SC 13D (2), 144/A (1), 4/A (1), 424B4 (1), 8-A12B (1), CERT (1), DRS (1), EFFECT (1), S-1 (1), S-8 (1), SC 13G/A (1)

  • Latest filingsAnnual report (10-K) Feb 26, 2026
    Quarterly report (10-Q) Aug 6, 2026
    Proxy statement (DEF 14A) Mar 17, 2026
    Latest 8-K (8-K) Sep 8, 2026

Securities registered for trading

ClassSymbolExchange
Common Stock, $0.01 par value per shareCONNew York Stock Exchange

From the cover page of the 10-K filed Feb 26, 2026 (Section 12(b) of the Exchange Act).4

Risk factors and legal proceedings

The risks Concentra Group Holdings Parent, Inc. names in Item 1A of its 10-K filed Feb 26, 2026: 63 risks under these headings, as written.4

  • Risks Related to Our Business, Industry and Operations
  • Risks Related to Financial and Economic Market Condition
  • Risks Related to Our Indebtedness
  • Risks Related to the Separation and the Distribution
  • Risks Related to Our Relationship with Select
  • Risks Related to Ownership of Our Common Stock
  • If the frequency of work-related injuries and illnesses decline, including if employment trends in the United States shift to industries that are less prone to workplace injuries and illness, our business, financial condition and results of operations may be negatively affected.
  • If we have adverse changes to our relationships with our significant employer customers, third-party payors, workers’ compensation provider networks or employer services networks, our business, financial condition and results of operations may be adversely affected.
  • We conduct business in a heavily regulated industry and changes to regulations, new interpretations of existing regulations, or violations of regulations may result in increased costs or sanctions that reduce our revenue and profitability.
  • We are subject to extensive fraud, waste, and abuse laws, and if we or our Managed PCs and their providers fail to comply with applicable healthcare laws and government regulations, we could be subject to sanctions and incur financial penalties, become excluded from participating in government healthcare programs, be required to make significant operational changes or experience adverse publicity, any or all of which could have a material adverse effect on our business, financial condition, and results of operations.
  • Cost containment initiatives or state fee schedule changes undertaken by state workers’ compensation boards or commissions and other third-party payors may adversely affect our revenue, profitability, and financial condition.
  • The nature of the markets that we serve may constrain our ability to realize reimbursement increases at rates sufficient to keep pace with the inflation of our costs.
The other 57 risks
  • Labor shortages, increased employee turnover, increases in employee-related costs, and union activity could have adverse effects including significant increases in our operating costs and a reduction in profitability.
  • If we fail to compete effectively with other occupational health centers, onsite health clinics at employer worksites, and healthcare providers in the local areas we serve, our revenue and profitability may decline.
  • A failure or security breach of our, or our third-party vendors’, information technology systems, such as a cyber-attack, may compromise our facilities, confidential data or critical data systems, result in harm to patients, subject us to potential legal and reputational harm, and otherwise have an adverse impact on our operations and business.
  • We may be adversely affected by negative publicity which can result in increased governmental and regulatory scrutiny and possibly adverse regulatory changes.
  • Significant legal actions could subject us to substantial uninsured liabilities.
  • We are subject to a variety of litigation, investigations and audits and other legal and regulatory proceedings and payor audits in the course of our business that could adversely affect our business and financial statements.
  • Noncompliance with billing and documentation requirements could result in non-payment or subject us to billing, coding or other compliance audits or investigations by government authorities or private payors.
  • Insurance coverage, even where available, may not be sufficient to cover losses we may incur.
  • Recent state laws that regulate healthcare costs, access to care and quality may impact our ability as a healthcare support service provider to do certain transactions.
  • Current and future acquisitions may use significant resources, may be unsuccessful, and could expose us to unforeseen liabilities.
  • We rely on third parties in many aspects of our business, which exposes us to additional risks that could adversely affect our business, financial condition and results of operations.
  • In conducting our business, we are required to comply with applicable laws regarding the corporate practice of medicine and therapy and professional fee-splitting.
  • We are dependent on our relationships with affiliated professional entities that we do not own to provide healthcare services, and our business would be harmed if those relationships were disrupted or if our arrangements with these entities become subject to legal challenges.
  • We are subject to extensive federal and state laws and regulations relating to the privacy of personal information, including protected health information, and any actual or perceived failure to comply could adversely affect our business, financial condition and results of operations.
  • If we fail to comply with applicable data interoperability and information blocking rules, it could materially adversely impact our business.
  • Facility licensure requirements in some states are costly and time-consuming, limiting or delaying our operations, and failure to comply with laws or regulation relating to permit, licensing and accreditation requirements, could result in fines, penalties and other adverse action, the loss of licenses, permits and accreditations and adversely affect our business and our financial condition.
  • If we are unable to maintain, protect or enforce our rights in our proprietary technology, brands or other intellectual property, our competitive advantage, business, financial condition and results of operations could be harmed.
  • If third parties claim that we infringe upon their intellectual property rights, our operations could be adversely affected.
  • Our business may be adversely impacted by changes and uncertainty in the healthcare industry, including healthcare public policy developments and other changes to laws and regulations.
  • Adverse economic conditions in the U.S. or globally could adversely affect us.
  • We are currently operating in a period of economic uncertainty and capital markets disruption, which has been significantly impacted by geopolitical instability due to ongoing conflicts in the Middle East and Russia and Ukraine and tensions between the United States and China and the United States and Venezuela. Our business, financial condition and results of operations could be adversely affected by any negative impact on the global economy, capital markets and supply chains resulting from such conflicts or any other geopolitical tensions.
  • Impairment of our goodwill and other intangible assets would result in a reduction in net income.
  • Our substantial indebtedness may limit the amount of cash flow available to invest in the ongoing needs of our business.
  • Our Credit Facilities require us to comply with certain covenants and obligations, the default of which may result in the acceleration of our Credit Facilities.
  • Payment of interest on, and repayment of principal of, our indebtedness is dependent in part on cash flow generated by our subsidiaries.
  • Despite our substantial level of indebtedness, we may be able to incur additional indebtedness. This could further exacerbate the risks described above, especially in the current rising interest rate environment.
  • We may be unable to refinance our debt on terms favorable to us or at all, which would negatively impact our business and financial condition.
  • Failure to maintain satisfactory credit ratings could adversely affect our liquidity, capital position, borrowing costs and access to capital markets.
  • We have a limited history of operating as a standalone public company, and our historical financial information may not fully reflect the results that we would have achieved as a standalone public company or what our results may be in the future.
  • We may not achieve all of the expected benefits of the Separation and the Separation could adversely affect our business, financial condition and results of operations.
  • If there is later a determination that certain steps of the Separation or the Distribution are taxable because the facts, assumptions, representations or undertakings underlying the IRS private letter ruling or any tax opinions are incorrect or for any other reason, then Select and its stockholders could incur significant U.S. federal income tax liabilities and we could incur significant liabilities through our indemnification obligations under the Tax Matters Agreement.
  • We may be affected by significant restrictions, including on our ability to engage in certain corporate transactions, for a two-year period following the completion of the Distribution in order to avoid triggering significant tax-related liabilities.
  • We have incurred and continue to incur significant charges in connection with the Separation and incremental costs as an independent, publicly traded company.
  • We are a smaller company relative to our former parent, Select, which could result in increased costs in our supply chain and in general because of a decrease in our purchasing power as a result of the Separation. We may also experience decreased revenue due to difficulty maintaining existing customer relationships and obtaining new customers.
  • Certain of our executive officers and directors may have actual or potential conflicts of interest because of their equity interest in Select. Also, certain of Select’s current executive officers and directors currently serve as our directors, which may create conflicts of interest or the appearance of conflicts of interest.
  • SMC may fail to perform under the Transition Services Agreement, or we may fail to have replacement systems and services in place when the Transition Services Agreement expires.
  • Potential indemnification obligations to SMC in connection with the Separation could adversely affect our business, financial condition and results of operations.
  • In connection with the Separation, SMC agreed to indemnify us for certain liabilities. However, we cannot assure you that the indemnity will be sufficient to insure us against the full amount of such liabilities or that Select’s ability to satisfy its indemnification obligation will not be impaired in the future.
  • Although under the Tax Matters Agreement the amount of our tax sharing payments to SMC was determined based upon the amount of tax attributable to Concentra for periods prior to the date of the Distribution, we nevertheless will have joint and several liability with Select for the consolidated U.S. federal income taxes of the Select consolidated group.
  • We may have received better terms from unaffiliated third parties than the terms we will receive in our agreements with Select and SMC.
  • We cannot be certain that an active trading market for our common stock will be sustained.
  • The stock price of our common stock may fluctuate significantly, and you could lose all or part of your investment in our common stock as a result.
  • The market price of shares of our common stock may be volatile, which could cause the value of your investment to decline.
  • If we are unable to implement and maintain effective internal control over financial reporting in the future, investors could lose confidence in the accuracy and completeness of our financial reports and the market price of shares of our common stock could be adversely affected.
  • The obligations associated with being an independent, publicly traded company require significant resources and management attention.
  • Your percentage ownership in us may be diluted in the future.
  • We are a holding company and our only material assets are our equity interests in our subsidiaries. As a consequence, we depend on the ability of our subsidiaries to pay dividends and make other payments and distributions to us in order to meet our obligations.
  • We cannot guarantee the payment of dividends on our common stock, or the timing or amount of any such dividends.
  • If our estimates or judgments relating to our critical accounting policies are based on assumptions that change or prove to be incorrect, our results of operations could be adversely affected, resulting in a decrease in the market price of shares of our common stock.
  • Certain provisions in our amended and restated certificate of incorporation and our amended and restated bylaws, and of Delaware law, may prevent or delay an acquisition of us, which could decrease the trading price of our common stock.
  • Our amended and restated certificate of incorporation provides that certain courts within the State of Delaware or the federal district courts of the United States will be the sole and exclusive forum for the resolution of certain types of actions and proceedings that may be initiated by our stockholders, which could discourage lawsuits against us and our directors, officers, employees and stockholders.
  • General Risk Factors
  • Public health threats such as a global pandemic, or widespread outbreak of infectious disease, may create uncertainties about our future operating results and financial conditions.
  • Our business operations could be significantly disrupted if we lose key members of our management team.
  • Our business depends on our ability to attract and retain talented, highly skilled employees and a diverse workforce, and on the succession of our senior management.
  • Climate change, or legal, regulatory or market measures to address climate change, could adversely affect our business, financial condition and results of operations.
  • Scrutiny and rapidly evolving expectations from stakeholders regarding ESG matters could adversely affect our business, financial condition and results of operations.
  • Changes in tax laws or exposures to additional tax liabilities could adversely affect our business, financial condition and results of operations.

Legal proceedings

Refer to the “Litigation” section contained within Note 18—“Commitments and Contingencies” of the notes to our consolidated financial statements included herein.

The opening of Item 3, Legal Proceedings.4

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49